Phase 3 HPV Infection Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Vaginal CancerCIN1CIN2+4 more
Shanghai Bovax Biotechnology Co., Ltd.1,348 enrolled1 locationNCT05027776
Recruiting
Phase 3
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Cervical CancerVaginal CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd.1,200 enrolled1 locationNCT04895020